This inventor holds 1 USPTO granted patent and 3 EPO patents. Top assignees: Institut Pasteur, Mcmaster University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Lida Katsimpardi: Innovator in Mood and Anxiety Disorder Research
Introduction
Lida Katsimpardi is an accomplished inventor based in Paris, France. She has made significant contributions to the field of mood and anxiety disorders through her research and innovative approaches. Although she currently holds no granted patents, her work is noteworthy and impactful.
Latest Patent Applications
Lida Katsimpardi's latest patent application is titled "Use of GDF11 to Diagnose and Treat Anxiety and Depression." This application outlines methods for detecting GDF11 in subjects with mood and anxiety disorders. The methods include providing a sample from the subject, contacting it with a GDF11-binding molecule, and detecting the bound GDF11. Additionally, the application describes methods for diagnosing or characterizing mood and anxiety disorders by comparing the levels of detected bound GDF11 to healthy reference levels. Furthermore, it provides methods for treating or preventing these disorders by administering an agent that increases GDF11 polypeptide levels in the subject.
Conclusion
Lida Katsimpardi's innovative research in the diagnosis and treatment of mood and anxiety disorders highlights her dedication to advancing medical science. Her contributions, although not yet reflected in granted patents, demonstrate her potential to make a significant impact in her field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile